{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:21:52Z","timestamp":1790742112520,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI073856"],"award-info":[{"award-number":["AI073856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI093570"],"award-info":[{"award-number":["AI093570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000965","name":"American Federation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000965","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ohio State University College of Medicine Systems in Integrative Biology Training Program"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vaccine.2015.08.033","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T00:18:30Z","timestamp":1440807510000},"page":"5035-5041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Prospects in Mycobacterium bovis Bacille Calmette et Gu\u00e9rin (BCG) vaccine diversity and delivery: Why does BCG fail to protect against tuberculosis?"],"prefix":"10.1016","volume":"33","author":[{"given":"Juan I.","family":"Moliva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi B.","family":"Torrelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.08.033_bib0475","unstructured":"WHO. WHO Tuberculosis Fact Sheet 2015, World Health Organization 15 A.D. March 20th, Available from: URL: \u3008http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/\u3009."},{"key":"10.1016\/j.vaccine.2015.08.033_bib0480","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"17 (May 5)","key":"10.1016\/j.vaccine.2015.08.033_bib0485","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0490","first-page":"789","article-title":"Tuberculosis vaccines","author":"Smith","year":"2012"},{"issue":"1 (Mar)","key":"10.1016\/j.vaccine.2015.08.033_bib0495","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0500","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0505","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0264-410X(93)90096-G","article-title":"Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen","volume":"11","author":"Lagranderie","year":"1993","journal-title":"Vaccine"},{"issue":"1 (Dec 8)","key":"10.1016\/j.vaccine.2015.08.033_bib0510","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0264-410X(03)00539-5","article-title":"Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums","volume":"22","author":"Aldwell","year":"2003","journal-title":"Vaccine"},{"issue":"12 (Mar 15)","key":"10.1016\/j.vaccine.2015.08.033_bib0515","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.vaccine.2005.11.017","article-title":"Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis","volume":"24","author":"Aldwell","year":"2006","journal-title":"Vaccine"},{"issue":"3 (Mar)","key":"10.1016\/j.vaccine.2015.08.033_bib0520","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1128\/IAI.73.3.1903-1905.2005","article-title":"Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis","volume":"73","author":"Aldwell","year":"2005","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2015.08.033_bib0525","doi-asserted-by":"crossref","first-page":"e45888","DOI":"10.1371\/journal.pone.0045888","article-title":"Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune response","volume":"7","author":"Ancelet","year":"2012","journal-title":"PLoS One"},{"issue":"14\u201315 (Nov)","key":"10.1016\/j.vaccine.2015.08.033_bib0530","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.micinf.2008.09.004","article-title":"Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection","volume":"10","author":"Vipond","year":"2008","journal-title":"Microbes Infect"},{"issue":"43 (Oct 8)","key":"10.1016\/j.vaccine.2015.08.033_bib0535","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1016\/j.vaccine.2010.07.087","article-title":"Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination","volume":"28","author":"Clark","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0540","doi-asserted-by":"crossref","first-page":"132583","DOI":"10.1155\/2012\/132583","article-title":"A single dose of oral BCG Moreau fails to boost systemic IFN-gamma responses to tuberculin in children in the rural tropics: evidence for a barrier to mucosal immunization","volume":"2012","author":"Vaca","year":"2012","journal-title":"J Trop Med"},{"issue":"2 (Mar)","key":"10.1016\/j.vaccine.2015.08.033_bib0545","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2223\/JPED.1146","article-title":"Percutaneous or intradermal BCG vaccine?","volume":"80","author":"Bricks","year":"2004","journal-title":"J Pediatr (Rio J)"},{"issue":"48 (Nov 12)","key":"10.1016\/j.vaccine.2015.08.033_bib0550","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.vaccine.2014.09.065","article-title":"The establishment of sub-strain specific WHO reference reagents for BCG vaccine","volume":"32","author":"Dagg","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0555","first-page":"1173","article-title":"BCG immunization of infants by percutaneous multiple puncture","volume":"52","author":"Glatthaar","year":"1977","journal-title":"S Afr Med J"},{"issue":"9 (Sep)","key":"10.1016\/j.vaccine.2015.08.033_bib0560","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/thx.54.9.762","article-title":"Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method","volume":"54","author":"Jarad","year":"1999","journal-title":"Thorax"},{"issue":"3 (Mar)","key":"10.1016\/j.vaccine.2015.08.033_bib0565","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2567.2002.01366.x","article-title":"Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies","volume":"105","author":"Hussey","year":"2002","journal-title":"Immunology"},{"issue":"8986 (Nov 18)","key":"10.1016\/j.vaccine.2015.08.033_bib0570","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0575","first-page":"455","article-title":"Effectiveness of BCG vaccination against tuberculosis meningitis","volume":"36","author":"Awasthi","year":"1999","journal-title":"Indian Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2015.08.033_bib0580","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/003655401300077144","article-title":"The challenge continues","volume":"33","author":"Fine","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0585","doi-asserted-by":"crossref","first-page":"a2052","DOI":"10.1136\/bmj.a2052","article-title":"Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial","volume":"337","author":"Hawkridge","year":"2008","journal-title":"Br Med J"},{"issue":"12 (Dec)","key":"10.1016\/j.vaccine.2015.08.033_bib0590","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","article-title":"Mycobacterial dose defines the Th1\/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route","volume":"66","author":"Power","year":"1998","journal-title":"Infect Immun"},{"issue":"10 (Oct)","key":"10.1016\/j.vaccine.2015.08.033_bib0595","first-page":"5657","article-title":"Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes","volume":"68","author":"Abolhassani","year":"2000","journal-title":"Infect Immun"},{"issue":"4 (Feb 15)","key":"10.1016\/j.vaccine.2015.08.033_bib0600","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/499825","article-title":"The effect of bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants","volume":"193","author":"Davids","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0605","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/clinids\/20.1.126","article-title":"Relationship between bacille Calmette-Gu\u00e9rin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis","volume":"20","author":"Brewer","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"2 (Feb)","key":"10.1016\/j.vaccine.2015.08.033_bib0610","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/CVI.00309-06","article-title":"Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates","volume":"14","author":"Davids","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","article-title":"Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCC vaccine strains","volume":"64","author":"Lagranderie","year":"1996","journal-title":"Infect Immun"},{"issue":"3 (Mar)","key":"10.1016\/j.vaccine.2015.08.033_bib0620","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","article-title":"Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis","volume":"74","author":"Castillo-Rodal","year":"2006","journal-title":"Infect Immun"},{"issue":"3 (Jan 14)","key":"10.1016\/j.vaccine.2015.08.033_bib0625","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","article-title":"Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis","volume":"27","author":"Horwitz","year":"2009","journal-title":"Vaccine"},{"issue":"Sep","key":"10.1016\/j.vaccine.2015.08.033_bib0630","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/MMBR.25.3.331-346.1961","article-title":"Immunological aspects of airborne infection: reactions to inhaled antigens","volume":"25","author":"Middlebrook","year":"1961","journal-title":"Bacteriol Rev"},{"issue":"3 (Mar)","key":"10.1016\/j.vaccine.2015.08.033_bib0635","first-page":"351","article-title":"Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin","volume":"107","author":"Barclay","year":"1973","journal-title":"Am Rev Respir Dis"},{"issue":"3 (Dec)","key":"10.1016\/j.vaccine.2015.08.033_bib0640","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/IAI.18.3.646-653.1977","article-title":"Induction and expression of immunity after BCG immunization","volume":"18","author":"Lefford","year":"1977","journal-title":"Infect Immun"},{"issue":"2 (Feb)","key":"10.1016\/j.vaccine.2015.08.033_bib0645","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/IAI.72.2.1065-1071.2004","article-title":"Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG","volume":"72","author":"Nuermberger","year":"2004","journal-title":"Infect Immun"},{"issue":"1 (Jan)","key":"10.1016\/j.vaccine.2015.08.033_bib0650","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun"},{"issue":"4 (May)","key":"10.1016\/j.vaccine.2015.08.033_bib0655","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2958.2003.03473.x","article-title":"Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG","volume":"48","author":"Rhoades","year":"2003","journal-title":"Mol Microbiol"},{"issue":"3 (May)","key":"10.1016\/j.vaccine.2015.08.033_bib0660","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tube.2004.10.001","article-title":"Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: haracterization of a new model of the granulomatous response to mycobacterial components","volume":"85","author":"Rhoades","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0665","series-title":"Understanding tuberculosis\u2014analyzing the origin of Mycobacterium tuberculosis pathogenicity","first-page":"1","article-title":"Broadening our view about the role of Mycobacterium tuberculosis cell envelope components during infection: a battle for survival","author":"Torrelles","year":"2012"},{"issue":"5 (Aug)","key":"10.1016\/j.vaccine.2015.08.033_bib0670","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0675","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M-bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0680","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"issue":"13 (Mar 27)","key":"10.1016\/j.vaccine.2015.08.033_bib0685","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10 (Oct)","key":"10.1016\/j.vaccine.2015.08.033_bib0690","first-page":"2733","article-title":"Mycolic acid patterns of representatives of Mycobacterium bovis BCG","volume":"130","author":"Minnikin","year":"1984","journal-title":"J Gen Microbiol"},{"issue":"7\u20138 (Feb 26)","key":"10.1016\/j.vaccine.2015.08.033_bib0695","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0264-410X(98)00277-1","article-title":"A historical and molecular phylogeny of BCG strains","volume":"17","author":"Behr","year":"1999","journal-title":"Vaccine"},{"issue":"7\u20138 (Jan 30)","key":"10.1016\/j.vaccine.2015.08.033_bib0700","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0264-410X(02)00577-7","article-title":"Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments","volume":"21","author":"Dietrich","year":"2003","journal-title":"Vaccine"},{"issue":"4 (Jul)","key":"10.1016\/j.vaccine.2015.08.033_bib0705","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","article-title":"Mapping the global use of different BCG vaccine strains","volume":"89","author":"Ritz","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"8","key":"10.1016\/j.vaccine.2015.08.033_bib0710","doi-asserted-by":"crossref","first-page":"e71243","DOI":"10.1371\/journal.pone.0071243","article-title":"Genome sequencing and analysis of BCG vaccine strains","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"4 (Feb)","key":"10.1016\/j.vaccine.2015.08.033_bib0715","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"10 (Jul)","key":"10.1016\/j.vaccine.2015.08.033_bib0720","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40265-013-0081-8","article-title":"Vaccine development for tuberculosis: current progress","volume":"73","author":"Orme","year":"2013","journal-title":"Drugs"},{"issue":"4 (Apr)","key":"10.1016\/j.vaccine.2015.08.033_bib0725","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies\u2014a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"Mar","key":"10.1016\/j.vaccine.2015.08.033_bib0730","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2014.11.026","article-title":"Tuberculosis vaccines\u2014state of the art, and novel approaches to vaccine development","volume":"32","author":"da Costa","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"6326","key":"10.1016\/j.vaccine.2015.08.033_bib0735","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.vaccine.2015.08.033_bib0740","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus Calmette-Gu\u00e9rin (BCG) vaccines expressing the Mycobacteirum tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9 (Sep)","key":"10.1016\/j.vaccine.2015.08.033_bib0745","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1128\/IAI.01499-13","article-title":"rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B","volume":"82","author":"Gillis","year":"2014","journal-title":"Infect Immun"},{"issue":"5 (May)","key":"10.1016\/j.vaccine.2015.08.033_bib0750","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2015.08.033_bib0755","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jmii.2012.11.005","article-title":"Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6","volume":"47","author":"Deng","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0760","doi-asserted-by":"crossref","first-page":"563838","DOI":"10.1155\/2012\/563838","article-title":"Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B","volume":"2012","author":"Wang","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"47 (Nov 5)","key":"10.1016\/j.vaccine.2015.08.033_bib0765","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","article-title":"Recombinant Mycobacterium bovis BCG","volume":"27","author":"Bastos","year":"2009","journal-title":"Vaccine"},{"issue":"1 (Feb)","key":"10.1016\/j.vaccine.2015.08.033_bib0770","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00430-002-0170-x","article-title":"Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis","volume":"193","author":"Dhar","year":"2004","journal-title":"Med Microbiol Immunol"},{"issue":"1 (Jan 1)","key":"10.1016\/j.vaccine.2015.08.033_bib0775","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","article-title":"Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells","volume":"27","author":"Badell","year":"2009","journal-title":"Vaccine"},{"issue":"2 (Feb)","key":"10.1016\/j.vaccine.2015.08.033_bib0780","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-3083.2007.02048.x","article-title":"Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57\/BL6 mice","volume":"67","author":"Qie","year":"2008","journal-title":"Scand J Immunol"},{"issue":"9 (May 1)","key":"10.1016\/j.vaccine.2015.08.033_bib0785","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/586902","article-title":"Efficacy of recombinant bacille Calmette-Guerin vaccine secreting interleukin-15\/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis","volume":"197","author":"Tang","year":"2008","journal-title":"J Infect Dis"},{"issue":"33 (Jul 16)","key":"10.1016\/j.vaccine.2015.08.033_bib0790","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2015.08.033_bib0795","doi-asserted-by":"crossref","first-page":"e78966","DOI":"10.1371\/journal.pone.0078966","article-title":"The tuberculosis vaccine candidate Bacillus Calmette-Guerin DeltaureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice","volume":"8","author":"Rao","year":"2013","journal-title":"PLoS One"},{"issue":"17\u201318 (Mar 18)","key":"10.1016\/j.vaccine.2015.08.033_bib0800","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.vaccine.2005.01.057","article-title":"Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model","volume":"23","author":"Kita","year":"2005","journal-title":"Vaccine"},{"issue":"1 (Jan)","key":"10.1016\/j.vaccine.2015.08.033_bib0805","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"issue":"7 (Oct 6)","key":"10.1016\/j.vaccine.2015.08.033_bib0810","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1084\/jem.186.7.1159","article-title":"pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes","volume":"186","author":"Beauregard","year":"1997","journal-title":"J Exp Med"},{"issue":"9 (Sep)","key":"10.1016\/j.vaccine.2015.08.033_bib0815","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Investig"},{"issue":"Jun 18","key":"10.1016\/j.vaccine.2015.08.033_bib0820","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guerin DeltaureC::hly vaccine's superior orotection against tuberculosis","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"issue":"17 (Sep 1)","key":"10.1016\/j.vaccine.2015.08.033_bib0825","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1158\/0008-5472.CAN-08-0161","article-title":"Efficient cross-presentation depends on autophagy in tumor cells","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res"},{"issue":"3 (Mar)","key":"10.1016\/j.vaccine.2015.08.033_bib0830","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat Med"},{"issue":"5 (May)","key":"10.1016\/j.vaccine.2015.08.033_bib0835","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/IAI.68.5.2948-2953.2000","article-title":"CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis","volume":"68","author":"Freidag","year":"2000","journal-title":"Infect Immun"},{"issue":"1 (Jan)","key":"10.1016\/j.vaccine.2015.08.033_bib0840","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/IAI.00897-06","article-title":"Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection","volume":"75","author":"Ryan","year":"2007","journal-title":"Infect Immun"},{"issue":"5 (May)","key":"10.1016\/j.vaccine.2015.08.033_bib0845","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/CVI.00034-08","article-title":"Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone","volume":"15","author":"Wedlock","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"4 (Jan 11)","key":"10.1016\/j.vaccine.2015.08.033_bib0850","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.vaccine.2012.11.042","article-title":"Prime-boost BCG vaccination with DNA vaccines based in beta-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model","volume":"31","author":"Cervantes-Villagrana","year":"2013","journal-title":"Vaccine"},{"issue":"1 (Jan)","key":"10.1016\/j.vaccine.2015.08.033_bib0855","first-page":"25","article-title":"Origin and development of RUTI, a new therapeutic vaccine against Mycobacterium tuberculosis infection","volume":"42","author":"Cardona","year":"2006","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0860","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"8 (Aug)","key":"10.1016\/j.vaccine.2015.08.033_bib0865","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.201040433","article-title":"Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung","volume":"40","author":"Redford","year":"2010","journal-title":"Eur J Immunol"},{"issue":"8 (Oct 15)","key":"10.1016\/j.vaccine.2015.08.033_bib0870","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.1201061","article-title":"Blockade of IL-10 signaling during bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection","volume":"189","author":"Pitt","year":"2012","journal-title":"J Immunol"},{"issue":"9871 (Mar 23)","key":"10.1016\/j.vaccine.2015.08.033_bib0875","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"issue":"11 (Nov)","key":"10.1016\/j.vaccine.2015.08.033_bib0880","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"issue":"3 (Aug 1)","key":"10.1016\/j.vaccine.2015.08.033_bib0885","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.08.033_bib0890","doi-asserted-by":"crossref","first-page":"e89612","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection","volume":"9","author":"Nell","year":"2014","journal-title":"PLoS One"},{"issue":"26 (May 30)","key":"10.1016\/j.vaccine.2015.08.033_bib0895","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.vaccine.2014.03.047","article-title":"Therapeutic vaccines for tuberculosis\u2014a systematic review","volume":"32","author":"Groschel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0900","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm0396-334","article-title":"Auxotrophic vaccines for tuberculosis","volume":"2","author":"Guleria","year":"1996","journal-title":"Nat Med"},{"issue":"11 (Nov)","key":"10.1016\/j.vaccine.2015.08.033_bib0905","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1128\/IAI.00531-06","article-title":"Protection elicited by two glutamine auxotrophs of Mycobacterium tuberculosis and in vivo growth phenotypes of the four unique glutamine synthetase mutants in a murine model","volume":"74","author":"Lee","year":"2006","journal-title":"Infect Immun"},{"issue":"1 (May 20)","key":"10.1016\/j.vaccine.2015.08.033_bib0910","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4049\/jimmunol.1100823","article-title":"Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection","volume":"187","author":"Arcos","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0915","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv146","article-title":"Lung mucosa lining fluid modifies Mycobacterium tuberculosis to reprogram human neutrophil killing mechanisms","author":"Arcos","year":"2015","journal-title":"J Infect Dis"},{"issue":"11 (Nov)","key":"10.1016\/j.vaccine.2015.08.033_bib0920","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1128\/IAI.00019-08","article-title":"Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice","volume":"76","author":"Jeon","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.08.033_bib0925","unstructured":"Frick M. The tuberculosis vaccines pipeline: a new path to the same destination? HIV-HCV-TB 2015 Pipeline Report\u2014TAG ibase, \u3008http:\/\/i-base.info\/htb\/28472\u3009; 2015."},{"key":"10.1016\/j.vaccine.2015.08.033_bib0930","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"5 (Nov)","key":"10.1016\/j.vaccine.2015.08.033_bib0935","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1165\/rcmb.2008-0154TR","article-title":"What animal models teach humans about tuberculosis","volume":"39","author":"Dharmadhikari","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9 (Mar 2)","key":"10.1016\/j.vaccine.2015.08.033_bib0940","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis, meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"J Am Med Assoc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15011597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T18:53:29Z","timestamp":1599504809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15011597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":94,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0264410X15011597"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects in Mycobacterium bovis Bacille Calmette et Gu\u00e9rin (BCG) vaccine diversity and delivery: Why does BCG fail to protect against tuberculosis?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}